Back to Top
Rovalpituzumab Vedotin Biosimilar - Research Grade
Add recommended extras
| Concentration | 1mg/ml |
|---|---|
| Isotype | IgG1 |
| Host | CHO Cells |
| Shipping Conditions | Room Temp |
| background | Anti-DLL3 Reference Antibody (rovalpituzumab-MMAE)(CHB294) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.02 kDa. |
| Other names | MMAE |
| Target | DLL3 |
| Species Reactivity | Human |
| Formulation | 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) |
| Purity | >90% by SDS-PAGE |
| Storage | This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
| Applications | Functional Assays |
| Application Notes | Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex. |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Delivery Time | 1 week |
Write Your Own Review
Who Viewed This Also Viewed
